ArticleFrontiers in human neuroscience2026
Role of AQP4 in ameliorating heat stress-induced cellular injury in a cell line model through active heat acclimation.
Article in Frontiers in human neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Heat stress (HS) can progress to heat stroke, a life-threatening condition. Aquaporin-4 (AQP4) has been implicated in HS-induced brain injury, but its role in heat acclimation (HA)-mediated protection remains unclear. This study investigated whether HA ameliorates HS-induced brain damage through AQP4. Methods: 9L/lacZ cells were randomly assigned to four groups: Control (37 °C, 5% CO₂), HA (39 °C, 5% CO₂, 2 h/day for 6 days), HS (43 °C, 5% CO₂, 2 h), and HA+HS (HA pretreatment followed by HS). In addition, cells in the Control and HS groups were treated with the selective AQP4 inhibitor TGN-020 (0.1 μmol/mL, 2 h before HS). The expression of HSP70, HSP90, and AQP4 was measured by western blotting; AQP4 mRNA levels were assessed by RT-PCR. Cell proliferation viability was evaluated by CCK-8 assay, and apoptosis was detected by flow cytometry. Results: Notably, AQP4 expression (RT-PCR and Western blot) was lower in the HA+HS group than in the HS group. Flow cytometry revealed that both HA+HS and TGN-020 treatment reduced apoptosis compared with HS alone. Discussion: These findings indicate that HA attenuates HS-induced injury by downregulating AQP4 expression, and that AQP4 inhibition mimics this protective effect. AQP4 represents a potential therapeutic target for heat stroke.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.